SET-171 is a JNK inhibitor with anticancer activity, demonstrating cytotoxicity against HepG2 and Huh7 liver cancer cells (IC50: 8.82 µM and 2.97 µM). It also shows potential in NAFLD research by reducing triglyceride levels and suppressing hepatic steatosis-associated proteins.
Molekulargewicht:
545.45
CAS Nummer:
[3052985-32-4]
Formel:
C27H21BrN4O2S
Target-Kategorie:
JNK,PKM
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten